Screenshot of text from Aid et al reading “In this study, we evaluated the immunological and inflammatory responses in people with LC compared with convalescent controls (CCs) at 90–180 days and more than 180 days after initial COVID-19 infection using immunological assays, virological assays, transcriptomics and proteomics. The first cohort was enrolled in 2020–2021, and the second cohort was enrolled in 2023–2024. Our data show that chronic inflammation, T cell exhaustion, metabolic dysregulation and upregulation of the JAK-STAT and interleukin-6 (IL-6) signaling pathways are key features of LC.”
In his substack review, @marcveld.bsky.social suggested that journals like Nature or Nature Immunology were better. Soon thereafter, Aid et al, “Long COVID involves activation of proinflammatory and immune exhaustion pathways”, Nature Immunology (2025), www.nature.com/articles/s41... was published.